Malignant Struma Ovarii: A Population-Level Analysis of a Large Series of 68 Patients
Abstract
BACKGROUND: Malignant struma ovarii (MSO) is a germ cell tumor of the ovary histologically identical to differentiated thyroid cancers. There is a paucity of data on this neoplasm, with fewer than 200 reported cases. The primary objective of this study was to examine the survival rate of women diagnosed with MSO using data from the Surveillance, Epidemiology, and End RESULTS (SEER) database. Secondary objectives were to describe the demographic, clinical, pathologic, and treatment characteristics of this population. METHODS: A retrospective analysis was performed of prospectively collected cancer registry data. A total of 68 patients were identified in the SEER database, 1973-2011. The chi-square test, Student's t-test, and Kaplan-Meier curves were employed for data analyses. RESULTS: All 68 patients were females with a mean age at diagnosis of 43.0 years. Nearly 33% underwent unilateral oophorectomy, 28.6% bilateral oophorectomy, and 28.6% oophorectomy and omentectomy, and 4.8% were treated with debulking surgery. Pelvic radiation was administered to 12.3% of patients. The mean tumor size was 52.8 mm; 80% of malignant struma ovarii were SEER staged as local. Overall survival rates at 5, 10, and 20 years were 96.7%, 94.3%, and 84.9% respectively. Among the patients, there were six deaths recorded; only one was attributed to MSO. Six individuals (8.8%) had a concomitant or subsequent diagnosis of thyroid cancer. Four patients underwent total thyroidectomy, three patients had radioactive iodine, and one patient underwent external beam radiation. Two thirds of thyroid cancers extended outside the thyroid gland. All six patients with thyroid cancer were alive at the end of follow-up. CONCLUSIONS: It was observed that patients with malignant struma ovarii had an excellent disease-specific survival rate, regardless of the management strategy employed. However, MSO patients had a high risk for developing aggressive thyroid cancers. Therefore, MSO patients may benefit from routine thyroid imaging once the diagnosis of MSO is established.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cosynchronous primary thyroid cancer occurred in 9% of patients in one series of 68 patients identified in the Surveillance, Epidemiology, and End Results database.
“Cosynchronous primary thyroid cancer occurred in 9% of patients in one series of 68 patients identified in the Surveillance, Epidemiology, and End Results database (664).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [664]
Cites
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,814 · see citing works
DeSimone, C. P., Lele, S. M., & Modesitt, S. C. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00141-0 · Cited by 228 · see citing works
Clinical characteristics of struma ovarii
Yoo, S., Chang, K., Lyu, M.-O., et al. (2008) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2008.19.2.135 · Cited by 216 · see citing works
Roth, L. M., & Talerman, A. (2007) · Pathology · doi:10.1080/00313020601123979 · Cited by 190 · see citing works
Malignant Struma Ovarii: An Analysis of 88 Cases, Including 27 With Extraovarian Spread
Robboy, S. J., Shaco‐Levy, R., Peng, R. Y., et al. (2009) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181a27777 · Cited by 183 · see citing works
Confidence Intervals for the Mean of a Poisson Distribution: A Review
Sahai, H., & Khurshid, A. (1993) · Biometrical Journal · doi:10.1002/bimj.4710350716 · Cited by 130 · see citing works
BRAF in Papillary Thyroid Carcinoma of Ovary (Struma Ovarii)
Schmidt, J., Derr, V., Heinrich, M. C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31802f5404 · Cited by 114 · see citing works
Yassa, L., Sadow, P. M., & Marqusee, E. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0887 · Cited by 110 · see citing works
Harlan, L. C., & Hankey, B. F. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.94.023 · Cited by 110 · see citing works
Marti, J. L., Clark, V. E., Harper, H. L., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0162 · Cited by 104 · see citing works
Coexistence of Malignant Struma Ovarii and Cervical Papillary Thyroid Carcinoma
Leong, A., Roche, P. J. R., Paliouras, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1782 · Cited by 46 · see citing works
Shrimali, R. K., Shaikh, G., & Reed, N. S. (2012) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/j.1754-9485.2012.02394.x · Cited by 38 · see citing works
Lethal, Malignant, Metastatic Struma Ovarii
Marcy, P., Thariat, J., Benisvy, D., et al. (2010) · Thyroid · doi:10.1089/thy.2010.0022 · Cited by 36 · see citing works
Coexistence of Malignant Struma Ovarii and Graves’ Disease
Sussman, S. K., Kho, S., Cersósimo, E., et al. (2002) · Endocrine Practice · doi:10.4158/ep.8.5.378 · Cited by 28 · see citing works
Malignant struma ovarii: A case report and review of the literature
Mattucci, M. L., Dellera, A., Guerriero, A., et al. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03346337 · Cited by 28 · see citing works
Synchronous papillary carcinoma thyroid with malignant struma ovarii: A management dilemma
Krishnamurthy, A., Ramshankar, V., Vaidyalingam, V., et al. (2013) · Indian Journal of Nuclear Medicine · doi:10.4103/0972-3919.121975 · Cited by 19 · see citing works
Role of the otolaryngologist in the treatment of struma ovarii
Wirtz, E. D., Bothwell, N. E., & Klem, C. (2009) · The Laryngoscope · doi:10.1002/lary.20733 · Cited by 11 · see citing works
Compensatory quadrant-hyperhidrosis after contralateral intrathoracic surgery: a case report
Brodoehl, S., Witte, O. W., & Güenther, A. (2013) · Journal of Medical Case Reports · doi:10.1186/1752-1947-7-24 · Cited by 8 · see citing works
Exact Nonparametric Confidence Bands for the Survivor Function
Matthews, D. E. (2013) · The International Journal of Biostatistics · doi:10.1515/ijb-2012-0046 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works
“Cosynchronous primary thyroid cancer occurred in 9% of patients in one series of 68 patients identified in the Surveillance, Epidemiology, and End Results database (664).”
BackgroundSelf-citation
- Authors
- Goffredo, P., Sawka, A. M., Pura, J., Adam, M. A., Roman, S. A., & Sosa, J. A.
- Affiliations
- Duke University (US)
- University Health Network (CA)
- Corresponding author
- Sosa, Julie Ann
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2015-02
- Volume
- 25
- Issue
- 2
- Pages
- 211-215
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W1957417179
- Cited by
- 118
- References
- 19
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 15 · 2023: 13 · 2022: 11 · 2021: 17 · 2020: 7 · 2019: 9 · 2018: 11 · 2017: 10 · 2016: 7 · 2015: 3
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thyroid (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research UK
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Surgery › Testicular diseases and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- malignant struma ovarii, ovarian germ cell tumor, differentiated thyroid cancer, survival, oophorectomy, pelvic radiation, SEER database
- MeSH terms
- Adolescent, Adult, Aged, Female, Humans, Middle Aged, Ovarian Neoplasms, Retrospective Studies, Struma Ovarii, Survival Rate, SEER Program, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review